SLSheng Li

Sheng Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sheng Li has a total of 14 co-authors. Here are the top co-authors by number of shared publications:

  • J. Yan

    Dahua Hosp Xuhui Dist, Shanghai 200237, Peoples R China

    1 shared publication
  • Jian Ni

    Institute of Nano Biomedicine and Engineering, Shanghai Engineering Research Centre for Intelligent Diagnosis and Treatment Instrument, Department of Instrument Science and Engineering, School of Electronic Information and Electrical Engineering, Shanghai Jiao Tong University, Shanghai, P. R. China

    1 shared publication
  • Lin Guo

    Department of Clinical Laboratory, Fudan University Shanghai Cancer Center, Shanghai, China

    1 shared publication
  • Renquan Lu

    Department of Clinical Laboratory, Shanghai Cancer Center, Fudan University, Shanghai, 200032, China.

    1 shared publication
  • W. Ye

    Department of Endocrinology; Dahua Hospital; Shanghai China

    1 shared publication
  • X. Li

    Department of Endocrinology; Zhongshan Hospital Affiliated to Dalian University; Dalian China

    1 shared publication

Latest Publications

  • RS11212617 is associated with metformin treatment response in type 2 diabetes in Shanghai local Chinese population

    by Y. Zhou, Y. Guo, W. Ye, Y. Wang, X. Li, Y. Tian, Z. Liu, S. Li, J. Yan

    Objective This study was designed to examine the relevance of single‐nucleotide polymorphism (SNP) rs11212617 with treatment success in type 2 diabetes patients from Shanghai local Chinese Han population. Methods We genotyped rs11212617 in incident metformin users of type 2 diabetes patients from Shanghai local Chinese Han population. Association between rs11212617 and changes in HbA1c, fasting plasma glucose and postprandial glucose level were analysed. Results Two hundred and seventy‐four incident metformin users were included in the study sample. The SNP rs11212617 was significantly associated with metformin response in Shanghai local Chinese Han population. Conclusion The rs11212617 is associated with a reduction in HbA1c, fasting plasma glucose and postprandial glucose level. These results suggest that metformin treatment may be more efficacious in Shanghai and valuable for Chinese daily clinical practice.


  • Open Access

    Association of an NFKB1 intron SNP (rs4648068) with gastric cancer patients in the Han Chinese population

    by Renquan Lu, Xiang Gao, Yin Chen, Jian Ni, Yongfu Yu, Sheng Li, Lin Guo

    Hyperactivation of nuclear factor-κB (NF-κB) is associated with various types of tumors. This study investigated the susceptibility of the rs4648068 A/G genotype in the intron region of NFKB1 to gastric cancer and the association of this polymorphism with clinicopathologic variables in gastric cancer patients. A hospital-based case–control study of 248 gastric cancer patients and 192 control individuals was conducted in Fudan University Shanghai Cancer Center (Shanghai, China). Single nucleotide polymorphism (SNP) rs4648068 genotype in NFKB1 from blood samples of a total of 440 people was analyzed by polymerase chain reaction-based genotyping. The frequencies of the AA, AG, and GG genotypes of the rs4648068 polymorphism were 31.5%, 47.2%, and 21.3% in the gastric cancer patients and 29.7%, 59.9%, and 10.4% in the control individuals, respectively. We found that the GG genotype was associated with a significantly increased risk of gastric cancer (P = 0.042). Furthermore, among the gastric cancer cases, the rs4648068 GG genotype was associated with high clinical stage (AOR = 2.27, 95% CI: 1.11- 4.66), lymph node involvement (AOR = 2.90, 95% CI = 1.40- 6.03) and serosa invasion (AOR = 2.78, 95% CI = 1.34- 5.75). However, rs4648068 genotypes were not associated with tumor differentiation in gastric cancer patients. Homozygous rs4648068 GG was associated with an increased risk of gastric cancer, especially for the lymph node status and serosa invasion in Han Chinese population.